Evidence map›Paper›PMID 22067907›Full record

ArticleThe American journal of pathology2012

Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine.

Thomas Gobbetti, Nicolas Cenac, Jean-Paul Motta, Corinne Rolland, Laurence Martin, Patricia Andrade-Gordon, Martin Steinhoff, Elisabetta Barocelli, Nathalie Vergnolle

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 34 citations in OpenAlex.

  1. It's a Trap!-Potential of Cathepsins in NET Formation.International journal of molecular sciences · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Protectin D1Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  11. Role of matrix metalloproteinase-8 as a mediator of injury in intestinal ischemia and reperfusion.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

Thomas GobbettiINSERM, U1043, UPS, Centre de Physiopathologie de Toulouse Purpan (CPTP), Toulouse, France.
Nicolas Cenac
Jean-Paul Motta
Corinne Rolland
Laurence Martin
Patricia Andrade-Gordon
Martin Steinhoff
Elisabetta Barocelli
Nathalie Vergnolle
Centre de Physiopathologie de Toulouse-Purpan · FRInserm · FRCentre National de la Recherche Scientifique · FRSpringhouse · USUniversité Fédérale de Toulouse Midi-Pyrénées · FRUniversity of California, San Francisco · USUniversity of Parma · IT

Funding

Cytokine Signaling in Neurons: Inflammation, Pain and PruritisR01AR059402 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEINHOFF, MARTIN · 2011 to 2013
$1.0M
NIAMS NIH HHS R01 AR059402
6 · The paper itself

Abstract

Proteases and proteinase-activated receptor (PAR) activation are involved in several intestinal inflammatory conditions. We hypothesized that serine proteases and PAR activation could also modulate the intestinal injury induced by ischemia-reperfusion (I-R). C57Bl/6 mice were subjected to 90 minutes of intestinal ischemia followed or not by reperfusion. Sham-operated animals served as controls. After ischemia, plasma and tissue serine protease activity levels were increased compared to the activity measured in plasma and tissues from sham-operated mice. This increase was maintained or further enhanced after 2 and 5 hours of reperfusion, respectively. Trypsin (25 kDa) was detected in tissues both after ischemia and 2 hours of reperfusion. Treatment with FUT-175 (10 mg/kg), a potent serine protease inhibitor, increased survival after I-R, inhibited tissue protease activity, and significantly decreased intestinal myeloperoxidase (MPO) activity and chemokine and adhesion molecule expression. We investigated whether serine proteases modulate granulocyte recruitment by a PAR-dependent mechanism. MPO levels and adhesion molecule expression were significantly reduced in I-R groups pre-treated with the PAR(1) antagonist SCH-79797 (5 mg/kg) and in Par(2)(-/-)mice, compared, respectively, to vehicle-treated group and wild-type littermates. Thus, increased proteolytic activity and PAR activation play a pathogenic role in intestinal I-R injury. Inhibition of PAR-activating serine proteases could be beneficial to reduce post-ischemic intestinal inflammation.

Indexed as

alpha-MacroglobulinsAnimalsBenzamidinesChemokinesCysteine Proteinase InhibitorsGranulocytesGuanidinesIntestine, SmallIschemiaLeucineMaleMiceMice, Inbred C57BLPeroxidaseProtease InhibitorsReceptor, PAR-1alpha-MacroglobulinsBenzamidinesChemokinesCysteine Proteinase InhibitorsE 64GuanidinesLeucinenafamostatPeroxidaseProtease InhibitorsReceptor, PAR-1Receptor, PAR-2Serine Proteinase InhibitorsTrypsin

Identifiers

PMID22067907
PMCPMC5818635
OpenAlexW2146379851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.